hbv
prototyp
viru
hepadnavirida
spheric
virus
icosahedr
symmetri
combin
partial
doublestrand
ds
dna
genom
virusencod
rt
within
baltimor
viru
classif
system
classifi
virus
base
genom
composit
replic
hepadnavirida
classifi
group
vii
sometim
refer
pararetrovirus
anim
virus
group
recent
famili
divid
genera
orthohepadnaviru
speci
infect
mammal
includ
primat
bat
avihepadnaviru
speci
infect
bird
howev
recent
discoveri
put
hepadnavirus
infect
indic
viral
famili
might
larger
initi
believ
figur
base
sequenc
divers
hbv
divid
genotyp
put
genotyp
figur
hepadnavirus
smallest
known
viral
genom
rang
kb
hbv
genom
approxim
figur
circular
partial
doubl
strand
hbv
genom
encod
polymeras
p
surfac
precorecor
c
x
protein
encod
discret
open
read
frame
orf
figur
hbv
produc
viral
rna
transcript
vari
length
translat
distinct
protein
figur
b
basic
genom
organ
common
hepadnavirus
although
x
gene
absent
avihepadnaviru
speci
except
vestigi
x
gene
duck
hepadnavirus
compact
natur
hepadnaviru
genom
multipl
overlap
read
frame
result
approxim
two
third
nucleotid
encod
function
genom
structur
encompass
viru
gene
regulatori
region
restrict
redund
within
code
region
figur
one
specif
exampl
ntermin
region
precor
protein
highli
conserv
among
orthohepadnaviru
speci
like
owe
constraint
overlap
encapsid
signal
epsilon
negativesens
genom
dna
strand
complementari
mrna
transcript
complet
held
circular
conform
overlap
end
genom
rang
bp
avihepadnaviru
speci
bp
orthohepadnaviru
speci
partial
doubl
strand
relax
circular
rcdna
hbv
virion
convert
coval
close
circular
dna
cccdna
insid
hepatocyt
nucleu
viral
polymeras
fill
partial
singlestrand
region
genom
figur
biogenesi
cccdna
includ
exact
mechan
dna
repair
partial
singlestrand
dna
region
rcdna
fulli
understood
like
cell
enzym
tyrosyldna
phosphodiesteras
contribut
cccdna
format
cleavag
hbv
p
viral
cccdna
extrem
stabl
persist
nucleu
viral
lifespan
cell
provid
transcript
templat
rna
speci
translat
viral
protein
figur
addit
persist
minichromosom
form
cccdna
hepadnaviru
dna
also
integr
host
woodchuck
integr
usual
occur
within
myc
protooncogen
eventu
caus
hcc
almost
infect
human
hbv
integr
occur
differ
site
within
genom
consequ
less
clear
although
chronic
hbv
infect
associ
liver
integr
hbv
dna
host
genom
gene
typic
remain
control
nativ
leav
integr
genom
sourc
hbv
surfac
antigen
hbsag
infect
infecti
viral
particl
contain
hbv
genom
secret
infect
hepatocyt
addit
smaller
subvir
particl
long
tubular
filament
particl
particl
empti
shell
form
lack
capsid
viru
genom
therefor
particl
typic
outnumb
infecti
virion
much
believ
involv
immun
evas
bind
neutral
potenti
promot
tcell
similar
particl
document
woodchuck
hbv
indic
common
role
orthohepadnaviru
infect
nine
differ
hbv
genotyp
defin
diverg
nucleotid
level
put
genotyp
j
character
isol
hbv
genotyp
divid
least
subtyp
diverg
wide
variat
observ
number
subtyp
describ
per
genotyp
tabl
substanti
differ
among
genotyp
geograph
distribut
transmiss
mode
clinic
outcom
includ
emerg
drug
resist
respons
tabl
howev
data
low
middleincom
furthermor
difficult
associ
differ
diseas
progress
outcom
hbv
genet
sequenc
vs
popul
behavior
coinfect
exposur
drug
hepatotoxin
human
genet
studi
focus
small
number
individu
rel
restrict
prospect
highresolut
genomewid
associ
studi
larg
number
patient
requir
determin
interact
human
viru
genom
affect
outcom
sequenc
data
indic
wide
variat
number
subtyp
within
genotyp
rang
genotyp
c
distinct
genotyp
e
g
h
j
consist
singl
subtyp
figur
molecular
clock
analysi
indic
genotyp
c
like
oldest
larg
number
subtyp
keep
protract
endem
associ
human
howev
challeng
studi
evolut
hbv
lack
tempor
structur
confound
molecular
clock
genotyp
f
h
smaller
number
subtyp
highli
diverg
genotyp
might
higher
rate
genotyp
f
higher
intersubtyp
divers
could
due
geograph
rang
popul
nativ
alaskan
latin
american
genotyp
b
c
associ
higher
rate
vertic
transmiss
genotyp
f
associ
earlier
progress
hcc
particularli
alaskan
nativ
routin
genotyp
analysi
hbv
infect
individu
clinic
practic
recommend
us
asiapacif
european
clinic
larg
result
affect
treatment
decis
howev
recent
european
us
guidelin
recogn
genotyp
variat
associ
respons
therapi
pegyl
interferon
alfa
treatment
recommend
patient
neg
hbv
e
antigen
hbeag
infect
genotyp
e
differ
stop
point
propos
patient
infect
genotyp
respond
new
therapi
develop
genotyp
subtyp
data
becom
wide
avail
develop
better
understand
effect
genotyp
treatment
outcom
robust
molecular
biolog
compar
bioinformat
studi
divers
hbv
strain
publish
sequenc
hbv
genotyp
b
c
togeth
account
publish
fulllength
genom
data
download
august
univers
accept
refer
sequenc
number
amino
acid
residu
provid
import
foundat
unifi
research
effort
mind
use
previous
publish
hbv
protein
point
refer
pinpoint
site
immun
epitop
within
hbv
consist
number
hbv
genom
challeng
genotypespecif
differ
genom
length
circular
genom
unifi
system
would
valuabl
similar
propos
number
base
refer
strain
consist
approach
propos
document
insert
delet
convent
hbv
number
base
molecular
clone
genom
typic
use
genotyp
genotyp
refer
strain
defin
genom
origin
ecori
restrict
site
gaatcc
nucleotid
start
embed
within
overlap
p
presenc
restrict
site
hypothet
mani
hbv
number
convent
alway
follow
sequenc
data
must
examin
realign
ensur
consist
sever
central
databas
hbv
sequenc
includ
hepseq
http
wwwhepseqorgpublicwebfrontmainphp
recent
studi
report
refer
sequenc
subtyp
genotyp
howev
unifi
set
refer
sequenc
hbv
genotyp
subtyp
differ
hcv
hiv
larg
sequenc
databas
consist
use
refer
sequenc
support
hbv
field
work
progress
toward
develop
unbias
method
wholegenom
sequenc
number
sequenc
deposit
databas
like
increas
consider
curat
align
valid
genotyp
subtyp
refer
sequenc
would
valuabl
resourc
research
ensur
compar
analys
conduct
base
consist
approach
intergenotyp
hbv
recombin
report
situat
rang
individu
case
report
recombin
reach
fixat
meet
criteria
classif
separ
genotyp
genotyp
subtyp
breakpoint
recombin
randomli
distribut
throughout
genotyp
base
ecori
number
convent
breakag
tend
occur
site
within
nucleotid
possibl
decreas
betweengenotyp
divers
observ
region
addit
genotyp
recombin
exampl
includ
b
c
recombin
part
mainland
east
asia
defin
subgenotyp
c
recombin
report
e
recombin
report
differ
part
c
g
recombin
report
patient
base
sequenc
stretch
g
recombin
sequenc
identifi
patient
sever
patient
intragenotyp
hbv
recombin
also
describ
genotyp
b
c
e
increas
frequenc
intragenotyp
recombin
strain
compar
genotyp
b
c
like
reflect
long
associ
welldefin
subtyp
refer
strain
could
use
identifi
recombin
event
explain
current
distribut
divers
viral
variant
predict
futur
evolutionari
direct
deep
sequenc
analys
increas
understand
hbv
divers
evolut
control
immun
respons
resist
treatment
dispar
clinic
outcom
success
secondgener
shortread
sequenc
synthesi
approach
roch
platform
hoffmannla
roch
basel
switzerland
illumina
san
diego
ca
thirdgener
longread
sequenc
technolog
advanc
sequenc
approach
summaris
supplementari
tabl
onlin
http
oxford
nanopor
technolog
oxford
scienc
park
uk
provid
radic
differ
approach
gener
sequenc
data
real
time
directli
sampl
produc
complet
genom
haplotyp
albeit
constraint
high
rate
error
basecal
algorithm
ng
studi
potenti
increas
understand
viral
divers
exampl
studi
detect
minor
variant
popul
low
associ
quasispeci
divers
treatment
outcom
hbeag
sever
factor
hamper
understand
natur
effect
intrahost
divers
hbv
studi
use
wholegenom
sequenc
analys
sequenc
output
bias
need
prior
dna
amplif
especi
viral
load
low
represent
rcdna
reservoir
rather
cccdna
sequenc
studi
hcv
found
divers
differ
region
genom
indic
contrast
biolog
region
world
hbv
endem
mix
infect
common
challeng
differenti
coinfect
true
recombin
use
current
sequenc
sever
ng
platform
includ
illumina
roch
reli
short
read
ampliconbas
approach
respect
therefor
fullgenom
reconstruct
individu
quasispeci
difficult
infer
multipl
genotyp
detect
develop
new
longread
sequenc
technolog
oxford
nanopor
technolog
pacif
bioscienc
menlo
park
ca
enabl
accur
haplotyp
reconstruct
increas
specif
recombin
strain
distinguish
mix
although
region
hbv
genom
highli
conserv
data
intrapati
divers
simultan
compet
evolutionari
pressur
creat
differ
subpopul
hbv
within
patient
quasispeci
popul
level
produc
divers
rcdna
popul
less
divers
stabl
cccdna
popul
differ
sequenc
polymorph
potenti
archiv
cccdna
figur
stabli
fix
viru
popul
mutant
genom
egress
virion
must
effect
compet
circul
wildtyp
virus
infect
hepatocyt
gener
cccdna
uniqu
popul
structur
maxim
potenti
pool
mutant
enabl
advantag
viru
adapt
within
patient
still
elimin
virus
deleteri
mutat
lessfit
rcdna
genom
might
persist
bypass
egress
recycl
directli
back
nucleu
replenish
viral
cccdna
popul
howev
model
base
observ
duck
clearli
document
human
hbv
certain
hbv
polymorph
delet
associ
specif
clinic
outcom
cirrhosi
hcc
exampl
includ
divers
pre
region
correl
progress
chronic
hbv
infect
howev
delet
pre
region
associ
hcc
patient
infect
hbv
genotyp
b
c
particular
pre
delet
nt
hbv
genotyp
c
larg
delet
result
splice
hbv
pregenom
rna
associ
advanc
liver
diseas
includ
mutat
basal
core
promot
detect
pyrosequenc
associ
increas
risk
diseas
progress
cirrhosi
hcc
patient
hbv
genotyp
b
c
viral
likewis
viral
divers
like
affect
respons
treatment
although
relat
clearli
defin
larg
studi
correl
higher
level
viru
divers
particularli
basal
core
promot
precor
region
lower
probabl
hbsag
studi
associ
hbv
heterogen
posit
effect
wide
rang
measur
use
assess
divers
hbv
infect
individu
broad
estim
viru
divers
made
use
pairwis
entropybas
detect
minor
variant
viral
popul
specif
polymorph
often
associ
drug
resist
detect
mixedgenotyp
subtyp
import
increas
understand
quasispeci
dynam
better
understand
select
fixat
polymorph
affect
patient
outcom
includ
viru
resist
drug
vaccin
antiviru
immun
respons
develop
chronic
liver
diseas
divers
viru
popul
could
aris
immun
select
pressur
balanc
benefit
immuneescap
mutat
deleteri
effect
mutat
hbv
fit
replic
capac
studi
pair
demonstr
rel
tight
bottleneck
transmiss
limit
viru
divers
infect
children
compar
proport
hbv
strain
mother
transfer
mother
hbv
hiv
coinfect
minor
hbv
variant
may
establish
domin
viru
infant
mutat
hbsag
frequent
observ
indic
hiv
infect
open
hbv
transmiss
bottleneck
analys
intrahepat
quasispeci
demonstr
associ
intrahepat
divers
focus
within
tcell
epitop
offtreat
control
indic
role
immunemedi
select
pressur
control
similarli
increas
divers
quasispeci
associ
effect
although
observ
bloodborn
viru
infect
intrapati
viru
divers
associ
strong
suppress
convers
poor
patient
howev
studi
factor
affect
divers
hbv
confound
factor
genotyp
subtyp
small
heterolog
cohort
variat
sequenc
method
examin
differ
area
genom
therefor
challeng
uncov
true
associ
studi
also
confound
geograph
distribut
genotyp
ethnic
affect
individu
chronic
hbv
infect
fundament
global
public
health
challeng
centuri
enough
unbias
gener
interpret
sequenc
data
attempt
unifi
data
relev
resourc
genom
annot
refer
sequenc
robust
link
clinic
data
develop
unbias
metagenom
pipelin
alongsid
care
collat
host
metadata
begun
affect
manag
patient
infecti
although
deep
sequenc
approach
robustli
appli
hbv
sever
situat
ng
data
could
substanti
valu
develop
diagnost
tool
select
treatment
analys
transmiss
studi
hbv
pathogenesi
viru
diagnost
ng
could
use
identifi
known
novel
virus
exclud
infecti
etiolog
clinic
previous
unrecogn
hbv
coinfect
detect
use
metagenom
approach
cohort
patient
acut
liver
new
splice
variant
identifi
use
pacif
bioscienc
time
ng
might
use
identifi
exist
new
drugresist
mutat
studi
strategi
develop
bring
genom
sequenc
analysi
clinic
virolog
exampl
pre
delet
pattern
combin
quantit
ng
data
machin
learn
method
might
use
identifi
patient
risk
liver
diseas
ng
also
might
use
character
vertic
transmiss
bottleneck
identifi
track
outbreak
rang
challeng
remain
widespread
applic
ng
platform
includ
need
deplet
host
read
could
requir
enrich
amplif
step
particularli
detect
virus
low
copi
number
system
reagent
expens
interpret
ng
data
requir
consider
bioinformat
support
adapt
differ
genom
configur
hbv
mean
refin
method
circular
partial
dsdna
genom
howev
develop
portabl
realtim
thirdgener
sequenc
platform
nanopor
minion
oxford
nanopor
technolog
made
prospect
deep
sequenc
point
care
test
increasingli
feasibl
rel
short
simpl
sampl
prepar
protocol
minim
setup
requir
laptop
comput
low
cost
rel
convent
benchtop
sequenc
make
technolog
particularli
appeal
resourcelimit
set
although
error
rate
nanopor
high
robust
applic
studi
pathogen
divers
rapid
improv
made
laboratori
bioinformat
substanti
gap
remain
understand
relationship
hbv
genom
structur
replic
cycl
divers
transmiss
clinic
outcom
recent
sequenc
advanc
offer
enorm
opportun
gener
dataset
help
address
question
gener
standard
refer
genom
hbv
genotyp
subtyp
enabl
robust
consist
collat
analysi
requir
develop
insight
current
futur
epidemiolog
inform
better
clinic
assess
prognost
improv
deploy
current
antivir
drug
vaccin
drive
discoveri
new
therapeut
agent
